Pages that link to "Q35602872"
Jump to navigation
Jump to search
The following pages link to Sample sizes for lesion magnetisation transfer ratio outcomes in remyelination trials for multiple sclerosis. (Q35602872):
Displaying 8 items.
- Imaging outcomes for trials of remyelination in multiple sclerosis (Q30620892) (← links)
- The role of MRI in the evaluation of secondary progressive multiple sclerosis. (Q31033345) (← links)
- Sample-size calculations for short-term proof-of-concept studies of tissue protection and repair in multiple sclerosis lesions via conventional clinical imaging (Q35925283) (← links)
- MRI in the assessment and monitoring of multiple sclerosis: an update on best practice (Q36400004) (← links)
- Assessing Repair in Multiple Sclerosis: Outcomes for Phase II Clinical Trials. (Q38659598) (← links)
- Acute optic neuritis: a clinical paradigm for evaluation of neuroprotective and restorative strategies? (Q43154346) (← links)
- Achievements and obstacles of remyelinating therapies in multiple sclerosis. (Q47835493) (← links)
- Imaging outcome measures of neuroprotection and repair in MS: A consensus statement from NAIMS (Q91760777) (← links)